Your browser doesn't support javascript.
loading
The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
Ahlén, Gustaf; Frelin, Lars; Nikouyan, Negin; Weber, Friedemann; Höglund, Urban; Larsson, Olivia; Westman, Marie; Tuvesson, Ola; Gidlund, Eva-Karin; Cadossi, Matteo; Appelberg, Sofia; Mirazimi, Ali; Sällberg, Matti.
Afiliação
  • Ahlén G; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
  • Frelin L; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
  • Nikouyan N; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
  • Weber F; Justus Liebig University Giessen, Giessen, Germany.
  • Höglund U; Adlego Biomedical AB, Uppsala, Sweden.
  • Larsson O; Adlego Biomedical AB, Uppsala, Sweden.
  • Westman M; Karolinska Trial Alliance, Karolinska University Hospital, Stockholm, Sweden.
  • Tuvesson O; Cobra Biologics, Matfors, Sweden.
  • Gidlund EK; Cobra Biologics, Matfors, Sweden.
  • Cadossi M; IGEA Spa, Carpi, Italy.
  • Appelberg S; Public Health Agency of Sweden, Solna, Sweden.
  • Mirazimi A; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
  • Sällberg M; Public Health Agency of Sweden, Solna, Sweden.
J Virol ; 94(18)2020 08 31.
Article em En | MEDLINE | ID: mdl-32661140

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Pandemias / Betacoronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Pandemias / Betacoronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article